SE8701592L - Farmaceutisk komposition som innehaller ett organiskt zinkkomplex samt forfarande for framstellning av den aktiva substansen - Google Patents

Farmaceutisk komposition som innehaller ett organiskt zinkkomplex samt forfarande for framstellning av den aktiva substansen

Info

Publication number
SE8701592L
SE8701592L SE8701592A SE8701592A SE8701592L SE 8701592 L SE8701592 L SE 8701592L SE 8701592 A SE8701592 A SE 8701592A SE 8701592 A SE8701592 A SE 8701592A SE 8701592 L SE8701592 L SE 8701592L
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
complex
zinc complex
formula
organic zinc
Prior art date
Application number
SE8701592A
Other languages
English (en)
Swedish (sv)
Other versions
SE8701592D0 (sv
Inventor
G Sebestyen
I Simonyi
G Miholics
M Kovacs
F Gorgenyi
M Fekete
P Vago
I Seres
J Egri
M Szeli
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of SE8701592D0 publication Critical patent/SE8701592D0/xx
Publication of SE8701592L publication Critical patent/SE8701592L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C07D215/30—Metal salts; Chelates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SE8701592A 1986-04-18 1987-04-16 Farmaceutisk komposition som innehaller ett organiskt zinkkomplex samt forfarande for framstellning av den aktiva substansen SE8701592L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU861623A HU196554B (en) 1986-04-18 1986-04-18 Process for production of medical compounds with fungicidal effect

Publications (2)

Publication Number Publication Date
SE8701592D0 SE8701592D0 (sv) 1987-04-16
SE8701592L true SE8701592L (sv) 1987-10-19

Family

ID=10955373

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8701592A SE8701592L (sv) 1986-04-18 1987-04-16 Farmaceutisk komposition som innehaller ett organiskt zinkkomplex samt forfarande for framstellning av den aktiva substansen

Country Status (24)

Country Link
US (2) US4868172A (es)
JP (1) JPS62294616A (es)
KR (1) KR870010036A (es)
CN (1) CN1021632C (es)
AU (1) AU601725B2 (es)
BE (1) BE1001251A4 (es)
BG (1) BG47945A3 (es)
CA (1) CA1306685C (es)
CH (1) CH671880A5 (es)
CS (1) CS269993B2 (es)
DE (1) DE3713372A1 (es)
DK (1) DK200087A (es)
ES (1) ES2005165A6 (es)
FI (1) FI871703A (es)
FR (1) FR2597343B1 (es)
GB (1) GB2189144B (es)
GR (1) GR870617B (es)
HU (1) HU196554B (es)
IL (1) IL82238A0 (es)
IT (1) IT1207583B (es)
NL (1) NL8700906A (es)
PL (1) PL265249A1 (es)
SE (1) SE8701592L (es)
YU (1) YU46313B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0355383A1 (de) * 1988-07-28 1990-02-28 Ciba-Geigy Ag Solubilisierungsverfahren
US5219847A (en) * 1989-06-12 1993-06-15 Shiseido Company, Ltd. Antipruritic composition
ATE112962T1 (de) * 1989-06-12 1994-11-15 Shiseido Co Ltd Mittel gegen juckreiz.
US7846919B2 (en) 1998-02-10 2010-12-07 Dermex Pharmaceuticals, Llc Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions
WO2012071577A2 (en) * 2010-11-25 2012-05-31 Zzakey Technologies Ltd. Biodegradable fire-fighting formulation
CN111937886A (zh) * 2019-05-16 2020-11-17 兰州大学 一种8-羟基喹啉配合物的制备及其在防治植物病害中的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH494760A (de) * 1962-11-30 1970-08-15 Metalsalts Corp Verfahren zur Herstellung von Metall-8-chinolinolaten mit Ausnahme der Alkalimetallderivate
US3886277A (en) * 1967-02-14 1975-05-27 Schwarzkopf Gmbh Hans Methods of controlling dandruff using 5,7-dichloro-8-hydroxy quinoline
BE755584A (fr) * 1969-09-19 1971-03-01 Ugine Kuhlmann Nouveaux medicaments a activite amoebicide
DE2154020A1 (de) * 1971-10-29 1973-05-03 Hoechst Ag Metallkomplexe von substituierten benzimidazolen
NO156672C (no) * 1975-10-24 1987-11-04 Chapman Chem Co Preparat med antimikrobiell og eventuelt insekticid virkning og anvendelse av et slikt preparat som tre- og vekstbeskyttelsesmiddel.
ZA786259B (en) * 1977-11-09 1979-10-31 Procter & Gamble Therapeutic composition
DE3129685C2 (de) * 1981-07-28 1986-11-06 geb. Stoffel Annemarie Dr. 7802 Merzhausen Buck Antiseptische Lösung

Also Published As

Publication number Publication date
HU196554B (en) 1988-12-28
GR870617B (en) 1987-08-18
YU69387A (en) 1988-12-31
KR870010036A (ko) 1987-11-30
US4868172A (en) 1989-09-19
JPS62294616A (ja) 1987-12-22
DK200087D0 (da) 1987-04-15
US4871728A (en) 1989-10-03
CS269993B2 (en) 1990-05-14
DE3713372A1 (de) 1987-10-22
CS203587A2 (en) 1989-04-14
AU7175887A (en) 1987-10-22
FR2597343A1 (fr) 1987-10-23
IL82238A0 (en) 1987-10-30
FI871703A (fi) 1987-10-19
AU601725B2 (en) 1990-09-20
NL8700906A (nl) 1987-11-16
GB8709166D0 (en) 1987-05-20
YU46313B (sh) 1993-05-28
ES2005165A6 (es) 1989-03-01
IT1207583B (it) 1989-05-25
GB2189144A (en) 1987-10-21
FI871703A0 (fi) 1987-04-16
CH671880A5 (es) 1989-10-13
CN1021632C (zh) 1993-07-21
BE1001251A4 (fr) 1989-09-05
HUT43781A (en) 1987-12-28
IT8720168A0 (it) 1987-04-17
FR2597343B1 (fr) 1991-11-29
SE8701592D0 (sv) 1987-04-16
CA1306685C (en) 1992-08-25
BG47945A3 (en) 1990-10-15
DE3713372C2 (es) 1991-12-19
JPH0525858B2 (es) 1993-04-14
CN87102747A (zh) 1987-12-09
DK200087A (da) 1987-10-19
GB2189144B (en) 1990-04-25
PL265249A1 (en) 1988-07-21

Similar Documents

Publication Publication Date Title
DE59010810D1 (de) Arzneimittel enthaltend als Wirkstoff R-alpha-Liponsäure oder S-alpha-Liponsäure
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
ES485188A1 (es) Procedimiento para preparar 1-piperazina-carboxamidas y car-botiamidas
GR77915B (es)
KR880006193A (ko) 피페리딘 화합물 및 그의 제조 및 용도
PT82368A (en) Substituted n-<(4-piperidinyl)alkyl> bicyclic condensed oxazol- and thiazolamines
FI854926A0 (fi) Foerfarande foer framstaellning av farmakologiskt aktiva pyrrolobensimidazoler.
KR890006644A (ko) 결정성 β-락탐 수화물
SE8701592L (sv) Farmaceutisk komposition som innehaller ett organiskt zinkkomplex samt forfarande for framstellning av den aktiva substansen
ES539123A0 (es) Un compuesto de 3-indolcarboxamida
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
DK552985D0 (da) Mercaptanderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DE3584608D1 (de) Amidabkoemmlinge.
KR890008136A (ko) 항균성 9-데옥소-9a-알릴 및 프로파길-9a-아자-9a-호모에리트로 마이신 A 유도체
GB997633A (en) Improvements in or relating to nitrofurfurylideneamino-hydantoins
ES552782A0 (es) Un procedimiento para preparar un compuesto de n-fenil-trans-4-guanidincometilciclohexanocarboxamida.
KR890003755A (ko) 7- (2- 메틸- 4- 아미노피롤리디닐)나프티리딘 및 퀴놀린 화합물
SE8802066D0 (sv) N-imidazolyl derivatives of bicyclic compounds useful in medicine
ATE19632T1 (de) Guanin-derivate.
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
ATE24834T1 (de) Verwendung von beta-(1-adamantyl)-alpha, alphadimethylethylamin zur herstellung eines arzneimittels zur behandlung von otitis externa bei hunden.
GB967594A (en) 2-(2,6-dimethyl-3-hydroxy-4-tert-butyl-benzyl)-2-imidazoline,and acid addition salts thereof,and process for their manufacture
KR890017259A (ko) 모액으로부터의 항생물질 회수방법 및 그의 약학적으로 허용할 수 있는 신규한 염
KR880006198A (ko) 2,6-디아미노-3- 할로벤질피리딘, 이의 제조방법 및 이의 약제학적 용도
EP0250508A1 (de) Arzneimittel zur behandlung von leberkrankheiten

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8701592-1

Effective date: 19940426